Nvidia's Arm Holdings takeover gets vote of support

Three top chipmakers have expressed support for Nvidia's controversial $40bn takeover of Arm Holdings. But it could still fail. Matthew Partridge reports

Semiconductor chip
Nvidia’s controversial takeover could come unstuck
(Image credit: © Matthew Horwood/Getty Images)

Nvidia’s proposed $40bn takeover of British semiconductor group Arm Holdings, which is being sold by Japan’s SoftBank Group, received a boost after three of the world’s largest chipmakers “expressed support” for the “controversial” deal, says Priscila Rocha on Bloomberg. Broadcom Corp, MediaTek and Marvell Technology Group are the first customers of Arm to speak out in favour of the takeover. Their support undermines claims from rival Qualcomm and tech giants including Microsoft that Nvidia could use its control of Arm to “limit the supply of the company’s technology to its competitors or raise prices”.

The apparent endorsement from several leading chip firms comes at a “crucial time” for Nvidia’s planned takeover, says Jamie Nimmo in The Sunday Times. This is because the UK competition watchdog is now “preparing to deliver its judgement” on the deal following a review on both competition and national security grounds – a process that has “cast doubt” on the tie-up taking place. The deal is also in the process of being scrutinised by other regulators in Europe, the United States and China – opposition from any one of which could effectively veto it.

Try 6 free issues of MoneyWeek today

Get unparalleled financial insight, analysis and expert opinion you can profit from.

Start your trial
https://cdn.mos.cms.futurecdn.net/flexiimages/mw70aro6gl1676370748.jpg

Sign up to Money Morning

Don't miss the latest investment and personal finances news, market analysis, plus money-saving tips with our free twice-daily newsletter

Don't miss the latest investment and personal finances news, market analysis, plus money-saving tips with our free twice-daily newsletter

Sign up
Latest Videos FromMoneyWeek
Dr Matthew Partridge
MoneyWeek Shares editor